| Thromboembolism |
0 |
0.9 |
| Cerebrovascular Accident |
0 |
0.95 |
| Surgery |
0 |
0.93 |
| Peripheral Artery Disease |
0 |
0.78 |
| Cardiac Surgery |
0 |
0.77 |
| Hypertension |
0 |
0.23 |
| Renal Failure |
0 |
0.15 |
| Hemorrhage |
0 |
0.14 |
| Myocardial Infarction (MI) |
0 |
0.12 |
| Antifibrinolytics |
0 |
0.95 |
| Blood |
0 |
0.1 |
| Dorsum |
0 |
0.1 |
| Grant |
0 |
0.1 |
| Perioperative Care |
0 |
0.1 |
| Thrombosis |
0 |
0.1 |
| Transfusion |
0 |
0.1 |
| Acute Kidney Injury |
0 |
0.09 |
| Antihypertensive Agents |
0 |
0.07 |
| Artery |
0 |
0.07 |
| Coronary Artery Disease (CAD) |
0 |
0.07 |
| Injury |
0 |
0.07 |
| Wound Management |
0 |
0.07 |
| Heart Failure (HF) |
0 |
0.06 |
| Venous Thromboembolism (VTE) |
0 |
0.06 |
| Adherence |
0 |
0.04 |
| Anticoagulation Therapy |
0 |
0.04 |
| Aspirin |
0 |
0.04 |
| B-Type Natriuretic Peptide |
0 |
0.04 |
| Beta Blockers |
0 |
0.04 |
| Canada |
0 |
0.04 |
| Europe |
0 |
0.04 |
| Hemoglobin |
0 |
0.04 |
| Hemophilia |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Hypotension |
0 |
0.04 |
| Infarction |
0 |
0.04 |
| Inpatient Care |
0 |
0.04 |
| Intravenous |
0 |
0.04 |
| Kidney |
0 |
0.04 |
| Pandemic |
0 |
0.04 |
| Seizure |
0 |
0.04 |